Stonepine Capital, L.P., 10% Owner at NOVELION THERAPEUTICS INC. (NVLNF), bought 9,700 shares at $0.70 ($7K) on 2019-12-09, disclosed to the SEC on 2019-12-09.
Open-market purchase of $7k NVLNF by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.70 | 5,160 | $4K | 53.2% |
| 2 | $0.70 | 40 | $28 | 0.4% |
| 3 | $0.70 | 4,500 | $3K | 46.4% |
| Total | $0.70 avg | 9,700 | $7K | 100% |
| Filing → |
| NVLNF | BUY | 2019-10-16 | $65K | — | Filing → |
| APEN | SELL | 2018-12-31 | $750K | — | Filing → |
| APEN | SELL | 2018-12-28 | $1.5M | — | Filing → |